The Drug Enforcement Administration works with practitioners to bring awareness to prescription drug diversion
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • The Drug Enforcement Administration works with practitioners to bring awareness to prescription drug diversion

The Drug Enforcement Administration works with practitioners to bring awareness to prescription drug diversion

Noviembre 09, 2018
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Brian McNeal
Phone Number: (571) 362-1498

DETROIT – The Drug Enforcement Administration and the Federation State of Medical Boards today hosted the Michigan Practitioner Diversion Awareness Training at Wayne State University in Detroit, Michigan.

Drug overdoses are the leading cause of injury-related deaths in the United States and the state of Michigan has been plagued by a disheartening amount of prescription drug-related overdoses. This crisis is destroying communities throughout our nation and every day we see the impact that drug abuse has on our neighborhoods. The objective of the Michigan Practitioner Diversion Awareness Training is to provide information and tools to address prescription drug abuse and addiction. Along with illicit narcotic enforcement, the DEA is responsible for preventing, detecting, and investigating the diversion of controlled pharmaceuticals. In addition to our regulatory efforts, DEA provides drug diversion education for practitioners and pharmaceutical companies to promote compliance. Today, participants of this training have been equipped with important information to help prevent prescription drug diversion as they collaborate with the DEA on this national issue.

Opening remarks for this training were given by the Special Agent in Charge of the Drug Enforcement Administration Detroit Field Division Timothy J. Plancon, and United States Attorney for the Eastern District of Michigan Matthew Schneider. Instruction was provided by experts from the DEA, Michigan Department of Licensing and Regulatory Affairs, U.S. Department of Health and Human Services, practitioners and others. Various topics were addressed including DEA’s Diversion Control mission, Michigan Automated Prescription Service and state legislative updates, health care fraud and diversion, electronic prescribing and addiction and medication–assisted treatment. Among today’s in-person and live stream sessions, approximately 1,000 of DEA’s nearly 53,000 Michigan registrants participated in this important event. The overwhelming attendance demonstrated a commitment from our medical community to improve the health and safety of our communities by reducing drug addiction and diversion.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Joseph O. Dixon Special Agent in Charge - Detroit
@DEADetroitDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster